Bigger Team

The US Food and Drug Administration may soon be able to add some 10 members to its inspection team in China, Pharmalot reports. The agency currently has one inspector based there as others became tangled up in visa snarls. Pharmalot's Ed Silverman notes that other inspectors have been working in China, though on a short-term basis

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.